Clinical audit of linezolid use in a large teaching hospital

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 2, 2005, Pages 423-426

  Ziglam, H M ^a   Elliott, I ^a   Wilson, V ^a   Hill, K ^a   Nathwani, D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antibiotic utilization; Glycopeptides; Staphylococcus aureus

Indexed keywords

GLYCOPEPTIDE; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; DRUG UTILIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MEDICAL AUDIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; RASH; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT INDICATION; UNITED KINGDOM; UTILIZATION REVIEW; VASCULAR ACCESS; VENTILATOR ASSOCIATED PNEUMONIA;

ACETAMIDES; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION REVIEW; GREAT BRITAIN; HOSPITALS, TEACHING; HUMANS; OXAZOLIDINONES;

EID: 23844475226     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki185     Document Type: Article

References (10)

1. Henwood CJ, Livermore DM, Johnson AP et al. Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. J Antimicrob Chemother 2000; 46: 931-40.
2. Moellering RC. Linezolid: The first oxazolidinone antimicrobial. Ann Intern Med 2003; 138: 135-42.
3. Nathwani D. Economic impact and formulary positioning of linezolid: A new anti-Gram-positive antimicrobial. J Hosp Infect 2001; 49 (Suppl A): S33-41.
4. Wilcox M, Nathwani D, Dryden M. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections. J Antimicrob Chemother 2004; 53: 335-44.
5. Parker SE, Nathwani D, O'Reilly D et al. Evaluation of the impact of non-inpatient iv antibiotic treatment for acute infections on the hospital, primary care services and the patient. J Antimicrob Chemother 1998; 42: 373-80.
6. Ioanas M, Lode H. Linezolid in VAP by MRSA: A better choice? Intensive Care Med 2004; 30: 343-6.
7. Rao N, Ziran BH, Hall RA et al. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004; 427: 67-71.
8. Rubinstein E, Isturiz R, Standiford HC et al. Worldwide assessment of linezolid's clinical safety and tolerability: Comparator-controlled phase III studies. Antimicrob Agents Chemother 2003; 47: 1824-31.
9. Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin Infect Dis 2004; 39: 1010-5.
10. Seaton RA, Nathwani D, Phillips G et al. Clinical record keeping in patients receiving antibiotics in hospital. Health Bull (Edinb) 1999; 57: 128-33.